NCT03284424 · Interventional trial
Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)
Overall registry status Completed
Phase 2
Conditions Squamous Cell Carcinoma
Delaware Valley sites
- Fox Chase Cancer Center ( Site 0351) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory